Background {#Sec1}
==========

Gastric cancer is the fourth most common cancer in the world \[[@CR1]\] and the second most common cancer in China \[[@CR2]\]. Surgical resection with extended lymph node clearance remains the only curative treatment for gastric cancer. It is often diagnosed at an advanced stage. Thus, the prognosis of gastric cancer is still not promising, even with the rapid advances in surgical techniques and adjuvant therapy \[[@CR3]\].

Tumor patients always tend to suffer from malnutrition and lose weight because of decreased oral intake and alterations in metabolism \[[@CR4]\]. The incidence of malnutrition in tumor patients is reported to be ranged from 10% to 85% according to the type, location and stage, etc. \[[@CR4]\]. Body mass index (BMI) was an effective measurement for evaluating nutritional status of cancer patients \[[@CR5]\]. In recent years, the associations between BMI and clinical outcomes of cancer patients have been widely investigated \[[@CR6]--[@CR9]\], including gastric cancer \[[@CR10]\]. Some studies reported that BMI was associated with postoperative complications \[[@CR4]\] and prognosis \[[@CR11]\] of gastric cancer. However, no association between BMI and clinical outcomes of gastric cancer has also been reported \[[@CR12], [@CR13]\].

Given this situation, the aim of the present study was to investigate the impact of BMI on the clinical outcomes of gastric cancer.

Methods {#Sec2}
=======

This study was performed in the Xijing Hospital of Digestive Diseases affiliated to the Fourth Military Medical University. From October 2008 to March 2015, 1210 gastric cancer patients treated with D2 gastrectomy were enrolled in the present study. All patients were treated with total, proximal or distal D2 gastrectomy. The surgical procedure was based on the recommendations of the Japanese Gastric Cancer Treatment Guidelines \[[@CR14]\]. The postoperative chemotherapy was given to patients according to the NCCN guideline for gastric cancer. This study was approved by the Ethics Committee of Xijing Hospital, and written informed consent was obtained from all patients before surgery.

Clinicopathological data including gender, age, BMI, tumor location, tumor size, Borrmann type, pathological type, type of gastrectomy, tumor depth, lymph node metastasis and tumor stage were collected. Surgery-related data including blood loss, operation time, number of retrieved lymph nodes and length of postoperative stay were recoded. Postoperative complications within 30 days including pneumonia, fever, wound disruption, wound infection, abdominal bleeding, anastomosis leakage, chyle leakage, gastric stasis, pleural effusion and ileus were also recorded through telephone and outpatient follow up. The survival of patients was followed up till November 2016 every 3 months.

BMI was calculated as body weight (kilograms) divided by height (meters) squared. Patients were divided into three groups according to BMI level: low BMI group (BMI \< 18.5 Kg/m^2^), normal BMI group (18.5 Kg/m^2^ ≤ BMI \< 25.0 Kg/m^2^) and high BMI group (BMI ≥ 25.0 Kg/m^2^).

To reduce bias, propensity score matching was used in our present study. The parameters used for propensity score matching was age, gender, tumor location, tumor size, type of resection, pathological type, tumor depth and LNM.

Data were processed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, USA). Discrete variables were analyzed using Chi-square test or Fisher's exact test. Continuous variables were expressed as median (interquartile range) and analyzed using nonparametric test. Significant prognostic risk factors identified by univariate analysis were further assessed by multivariate analysis using the Cox's proportional hazards regression model. Overall survival was analyzed by Kaplan-Meier method. The *P* value was considered to be statistically significant at 5% level.

Results {#Sec3}
=======

There were 949 male (78.4%) and 261 female (21.6%). The median age was 59 years (20--87). There were 107 patients in the low BMI group (8.9%), 862 patients in the normal BMI group (71.2%) and 241 patients in the high BMI group (19.95%). The median follow-up of the low, normal and high BMI group was 22.4 (1.3--66.2) months, 25.0 (1.4--73.5) months and 25.0 (1.6--74.6) months, respectively. The associations between clinicopathological characteristics and BMI were summarized in Table [1](#Tab1){ref-type="table"}. The results showed that BMI was not associated with age, gender, tumor location, Borrmann type, differentiation status and type of resection (all *P* \> 0.05). However, BMI was inversely associated with tumor size, tumor depth, LNM and tumor stage (all *P* \< 0.05).Table 1Correlation between clinicopathological characteristics and BMI before matchingCharacteristicsLow BMI\
(*n* = 107)Normal BMI\
(*n* = 862)High BMI\
(*n* = 241)*P* valueGender Male836771890.974 Female2418552Age  ≤ 60665011340.558  \> 6041361107Tumor location Upper third33300920.327 Middle third1515531 Lower third53349100 Entire65818Tumor size (cm)  ≤ 5615741750.016  \> 54628866Borrmann type I19102340.498 II2923259 III3730584 IV126413Pathological type Well differentiated674240.511 Moderately differentiated2221868 Poorly differentiated74540140 Signet ring cell or Mucinous5309Type of gastrectomy Proximal778250.594 Distal4131697 Total59468119Tumor depth T110161520.047 T2107130 T33930886 T4a4631572 T4b271Lymph node metastasis N023291990.005 N12014149 N22015333 N3a2618245 N3b189515Tumor stage Ia8140470.006 Ib35017 IIa1010034 IIb1912245 IIIa2110927 IIIb1616337 IIIc3017834

To reduce bias, propensity score matching was used to match patients in the three groups. After matching, there were 104 patients in the low BMI group, 416 patients in the normal BMI group and 104 patients in the high BMI group. The clinicopathological features were comparable among the three groups after matching (Table [2](#Tab2){ref-type="table"}, all *P* \> 0.05).Table 2Correlation between clinicopathological characteristics and BMI after matchingCharacteristicsLow BMI\
(*n* = 104)Normal BMI\
(*n* = 416)High BMI\
(*n* = 104)*P* valueGender Male82331760.353 Female228528Age  ≤ 6060220620.379  \> 604419642Tumor location Upper third33156370.329 Middle third156213 Lower third5116041 Entire53813Tumor size (cm)  ≤ 560251600.818  \> 54416544Borrmann type I1959110.682 II2711032 III3716242 IV11357Pathological type Well differentiated62340.746 Moderately differentiated219429 Poorly differentiated7228465 Signet ring cell or Mucinous5156Type of gastrectomy Proximal73660.816 Distal4114838 Total5623260Tumor depth T11050120.721 T2103514 T33914340 T4a4418438 T4b140Lymph node metastasis N023105220.730 N1206119 N2208716 N3a2510533 N3b165814Tumor stage Ia840100.280 Ib3246 IIa10399 IIb195916 IIIa214112 IIIb1610926 IIIc2710425

The association between BMI and surgery-related parameters were shown in Table [3](#Tab3){ref-type="table"}. The results showed that patients in the high BMI group was associated with increased blood loss and operation time, and deceased number of retrieved lymph nodes (all *P* \< 0.05). The length of postoperative stay was comparable among the three groups (*P* = 0.179).Table 3Comparison of surgery-related parameters after matchingCharacteristicsLow BMINormal BMIHigh BMI*P* valueBlood loss (ml)150 (100, 200)150 (100, 200)200 (150, 350)\< 0.001Operation time (min)170 (140, 220)185 (150, 230)217.5 (175, 263.75)\< 0.001Number of retrieved lymph nodes26 (22, 33)26 (21, 32)23 (19, 27)\< 0.001Length of postoperative stay7 (6, 9)7 (6, 9)8 (6, 9)0.179

The association between BMI and postoperative complications were shown in Table [4](#Tab4){ref-type="table"}. The results showed that patients in the low BMI group was associated with decreased rate of postoperative fever (*P* = 0.025). However, BMI was not associated with other complications (all *P* \> 0.05).Table 4Comparison of postoperative complications after matchingComplicationsLow BMINormal BMIHigh BMI*P* valueFever874210.025Pneumonia63280.788Wound infection0100.778Wound disruption0420.364Anastomosis leakage0900.102Abdominal bleeding1400.604Chyle leakage2500.405Pleural effusion11110.382Gastric stasis0010.082Ileus1820.794

The risk factors for the prognosis of gastric cancer patients were analyzed using univariate analysis and shown in Table [5](#Tab5){ref-type="table"}. The results showed that age, BMI, tumor size, Borrmann type, pathological type, type of gastrectomy, tumor depth, LNM and tumor stage were associated with the prognosis of gastric cancer. Multivariate analysis showed that only BMI, tumor size, tumor depth and LNM were independent prognostic factors (Table [6](#Tab6){ref-type="table"}).Table 5Univariate analysis of risk factors for prognosis of gastric cancer after matchingPrognostic factorsβHazard ratio (95% CI)*P* valueGender−0.1270.881(0.643--1.206)0.428Age0.3261.386(1.075--1.786)0.012BMI−0.2560.774(0.619--0.969)0.025Tumor location0.0561.058(0.933--1.199)0.380Tumor size0.7692.158(1.670--2.787)\< 0.001Borrmann type0.3571.429(1.260--1.621)\< 0.001Pathological type0.4671.596(1.289--1.975)\< 0.001Type of gastrectomy0.4320.649(0.522--0.808)\< 0.001Tumor depth0.8542.348(1.929--2.858)\< 0.001Lymph node metastasis0.5911.807(1.586--2.058)\< 0.001Tumor stage1.2393.451(2.575--4.623)\< 0.001Table 6Multivariate analysis of risk factors for prognosis of gastric cancer after matchingPrognostic factorsβHazard ratio (95% CI)*P* valueAge0.1981.219(0.940--1.582)0.136BMI0.3320.717(0.570--0.903)0.005Tumor size0.3451.412(1.077--1.851)0.013Borrmann type0.0801.083(0.943--1.244)0.259Pathological type0.1201.128(0.900--1.414)0.297Type of gastrectomy−0.0650.937(0.743--1.181)0.582Tumor depth0.5601.751(1.397--2.193)\< 0.001Lymph node metastasis0.4031.496(1.298--1.724)\< 0.001

The overall survival of gastric cancer patients stratified by BMI was shown in Fig. [1](#Fig1){ref-type="fig"}. The overall survival of patients with low BMI was significantly worse than patients with normal (*P* \< 0.001) or high BMI (*P* \< 0.001). However, the overall survival was comparable between patients with normal and high BMI (*P* = 0.150). Further, the overall survival of patients stratified by tumor stage were analyzed. For stage I patients, the overall survival was comparable among the three groups (*P* = 0.753). For stage II patients, the overall survival of patients with low BMI was significantly worse than that with normal (*P* = 0.032) or high BMI (*P* = 0.023). The overall survival of patients with normal and high BMI was comparable (*P* = 0.458). For stage III patients, the overall survival of patients with low BMI was significantly worse than that with normal (*P* \< 0.001) or high BMI (*P* = 0.004). The overall survival of patients with normal and high BMI was comparable (*P* = 0.783).Fig. 1Overall survival of gastric cancer patients stratified by BMI before matching

The overall survival was also analyzed for patients after propensity score matching (Fig. [2](#Fig2){ref-type="fig"}). The overall survival of patients with low BMI was significantly worse than patients with normal (*P* = 0.001) or high BMI (*P* = 0.031). However, the overall survival was comparable between patients with normal and high BMI (*P* = 0.731). Further, the overall survival of patients stratified by tumor stage were analyzed. For stage I and II patients, the overall survival was comparable among the three groups (both *P* \> 0.05). For stage III patients, the overall survival of patients with low BMI was significantly worse than that with normal (*P* = 0.003) or high BMI (*P* = 0.025). The overall survival of patients with normal and high BMI was comparable (*P* = 0.954).Fig. 2Overall survival of gastric cancer patients stratified by BMI after matching

Discussion {#Sec4}
==========

BMI is a widely used parameter in clinical practice due to easy measurement. BMI is associated with a variety of cancer, including gastric cancer \[[@CR15]\]. A meta-analysis has demonstrated that high BMI was associated with increased risk of gastric cardia cancer \[[@CR16]\]. The association between BMI and clinical outcomes of gastric cancer has also been widely investigated, however, it was still under debate \[[@CR10]--[@CR13]\]. Thus, the present study aims to investigate the impact of BMI on the clinical outcomes of gastric cancer after radical gastrectomy. We found that BMI was inversely associated with tumor stage. High BMI group was associated with increased blood loss and operation time, and deceased number of retrieved lymph nodes. Low BMI group was associated with decreased rate of postoperative fever and decreased survival of patients.

The association between BMI and tumor stage was inconsistent in previous reports. Kim et al. reported that low BMI was associated with more advanced tumor stage \[[@CR4]\]. Chen et al. reported that low BMI was associated with increased rate of lymph node metastasis and advanced tumor stage, but not associated with tumor depth \[[@CR11]\]. However, no association between BMI and tumor stage has also been reported \[[@CR12], [@CR17]\]. The inconsistent results may attribute to many reasons, such as inclusion and exclusion criteria, sample size, cut off value of BMI, race, etc. As gastrointestinal malignancy, gastric cancer always accompanied with severe weight loss and cachexia \[[@CR18]\]. Thus, advanced gastric cancer may be more inclined to exist in patients with low BMI. In our present study, we also found that BMI was inversely associated with tumor depth, lymph node metastasis and tumor stage.

The impact of BMI on intraoperative conditions were also widely investigated. Patients with high BMI was reported to be associated with increased blood loss \[[@CR19], [@CR20]\], increased operation time \[[@CR17], [@CR21]\] and decreased number of retrieved lymph nodes \[[@CR10], [@CR22]\] in most of previous reports. However, no association between BMI and intraoperative conditions has also been reported \[[@CR23], [@CR24]\] occasionally. Based on clinical experiences, obesity was thought to be associated with thick abdominal wall and massive adipose tissue in the abdomen, which will increase the difficulty of surgical resection \[[@CR17]\]. Thus, the blood loss was increased and operation time was prolonged \[[@CR11]\]. Furthermore, lymph nodes located deep in adipose tissue around major vessels were always difficult to remove in high BMI patients \[[@CR10]\]. In our present study, we also found that high BMI was also associated with increased blood loss, operation time and decreased number of retrieved lymph nodes. No difference was found between low and normal BMI patients. The results were consistent with most of the previous reports.

From the surgical point of view, high BMI patients was thought to be associated with increased postoperative complications due to the prolonged operation time and increased blood loss. This has been confirmed by most of the previous reports. Kulig et al. reported that higher BMI was associated with higher rates of intra-abdominal abscess and cardiopulmonary complications \[[@CR22]\]. Kim et al. also reported that obese was associated with higher rate of intra-abdominal abscess, wound problems and overall complications \[[@CR20]\]. Hirao et al. showed that overweight was an independent risk factor for surgical site infection \[[@CR19]\]. This risk may attribute to greater wound size and decreased oxygen tension in relatively avascular adipose tissue in overweight patients \[[@CR19]\]. In addition, high BMI was also reported to be associated with anastomotic leak \[[@CR10]\]. Theoretically, massive abdominal adipose tissue would result in a thick mesentery and increased tension on an anastomosis, which may result in anastomotic leakage \[[@CR10]\]. However, no association between BMI and postoperative complications was also reported \[[@CR12], [@CR17]\]. In our present study, we found that normal and high BMI group was associated with increased rate of postoperative fever. The inconsistence of the results may attribute to sample size, type of gastrectomy, surgical techniques and perioperative nursing and treatment.

It was well known that overweight and obesity was a risk factor of death in general population \[[@CR25]\]. However, "obesity paradox" has been proposed recently, referring to better prognosis of mildly obese patients after surgery \[[@CR11]\]. The association between BMI and prognosis of patients after radical gastrectomy has also been widely investigated. Chen et al. reported that BMI was inversely associated with the prognosis of patients \[[@CR11]\]. Tokunaga et al. reported that overweight patients had better prognosis after gastrectomy \[[@CR26]\]. However, also with relatively large sample size, no association was found between BMI and prognosis of gastric cancer \[[@CR10], [@CR22], [@CR27]\]. In our present study, low BMI was associated with decreased prognosis of gastric cancer. However, the prognosis was comparable between patients with normal and high BMI. It was reported that gastrectomy may result in 5%--19% body weight loss \[[@CR26]\]. Thus, overweight patients may achieve ideal body weight years after gastrectomy, which may result in better prognosis. It was reported that cancer patients with low BMI was always accompanied by low hemoglobin and albumin levels which may due to poor nutritional status and cachexia \[[@CR11]\]. The malnutrition in turn will impair the anti-tumor immunity of patients \[[@CR28]\]. In the subgroup analysis in our present study, only the prognosis of patients with stage III disease was significantly influenced by BMI, which indicated that patients with normal and high BMI might be more able to bear cancer related malnutrition and stress.

There were several limitations in our present study. First, it was a single center's experience with limited sample size, which may result in bias during analysis. Multi-center study with larger sample size was needed to confirm our results. Second, we only analyzed the impact of BMI at diagnosis on the clinical outcomes of patients. The impact of body weight loss before surgery on the clinical outcomes of patients were not analyzed. Third, as there were only twenty-three obese patients (BMI ≥ 30 Kg/m^2^) in our present study. We only divided patients into low, normal and high BMI groups. The impact of obesity on the clinical outcomes of gastric cancer was not independently analyzed. Fourth, it was reported that visceral fat area may be superior to BMI to predict the risk of gastrectomy. With regret, visceral fat area of patients was not evaluated in our present study.

Conclusions {#Sec5}
===========

BMI was inversely associated with tumor size, tumor depth, LNM and tumor stage. High BMI was associated with increased blood loss and operation time, and deceased number of retrieved lymph nodes. Low BMI was associated with decreased rate of postoperative fever and decreased survival of patients.
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:   lymph node metastasis
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